Fiche centre
Tongji Hospital, Tongji Medical College of HUST
Wuhan — China
Essais liés2clinical trials
VilleWuhanlocalisation
PaysChinalocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT06486441
Essais cliniques associés
2| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| SYS6020 injection | SEP | Phase 1/2 | NCT07756268 | Phase Ib/II Study of SYS6020 in Relapsing/Refractory Multiple Sclerosis | NOT_YET_RECRUITING |
| Sacituzumab govitecan-hziy | Cancer | Phase 3 | NCT06486441 | Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) | ACTIVE_NOT_RECRUITING |